A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.
about
Effects of complement activation on allograft injuryHuman astroviruses.Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of DiseaseInhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.Viral-derived complement inhibitors: current status and potential role in immunomodulation.Complement in Kidney TransplantationDiscriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and MyoglobinComplement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.
P2860
Q26995453-F62D802B-23B5-4D22-8F3E-4B52DC78F773Q34441542-134DCE58-E59D-4A01-BD23-0B3AEB30E368Q35701952-F972B2C7-3374-4020-AFB2-950EA335DC6CQ35862436-912FE99F-D070-42E9-98F7-FF060257164FQ36263903-44F4979F-DB41-4871-B56A-985A02717347Q38247280-611A3C28-B998-47F4-819B-8DB9D7E47EC5Q38995165-5B901C97-E44C-44A6-AA3B-6311057163DDQ39371134-2B51C61F-DEFA-41FF-94D6-A32F1BD82226Q40113202-11948985-63EB-4C31-A0EA-4F02893AA7AFQ41869157-B3CA321E-DD78-48AB-BA88-74B3636C2591Q42730527-C4C04515-F1F3-452C-AA35-1BD395CE0B8EQ44997808-5DFEA6B5-2E28-40F5-9D4C-4FC82F925A63Q45035787-1FC76B69-AB89-4212-8613-66CE73F89546Q45049365-1FC8D70B-9B58-4D32-8DD7-962B4B569865Q52327307-E57354DD-2B4D-4D24-8448-963FE52EC119
P2860
A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A novel peptide inhibitor of c ...... including ABO incompatibility.
@en
A novel peptide inhibitor of c ...... including ABO incompatibility.
@nl
type
label
A novel peptide inhibitor of c ...... including ABO incompatibility.
@en
A novel peptide inhibitor of c ...... including ABO incompatibility.
@nl
prefLabel
A novel peptide inhibitor of c ...... including ABO incompatibility.
@en
A novel peptide inhibitor of c ...... including ABO incompatibility.
@nl
P2093
P2860
P1433
P1476
A novel peptide inhibitor of c ...... including ABO incompatibility
@en
P2093
Cees van Kooten
Clifford T Mauriello
Frank A Lattanzio
Haree K Pallera
Jon L Woltmann
Julia A Sharp
Kenji M Cunnion
Pamela S Hair
Pieter van der Pol
Shizhi Qian
P2860
P304
P356
10.1016/J.MOLIMM.2012.07.012
P577
2012-08-18T00:00:00Z